Related references
Note: Only part of the references are listed.beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia
Y. Hu et al.
LEUKEMIA (2009)
Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice
Y. Chen et al.
LEUKEMIA (2009)
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence
I. Bruns et al.
LEUKEMIA (2009)
Cancer Stem Cell-Directed Therapies: Recent Data From the Laboratory and Clinic
Christopher Y. Park et al.
MOLECULAR THERAPY (2009)
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Chen Zhao et al.
NATURE (2009)
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Yaoyu Chen et al.
NATURE GENETICS (2009)
Stems cells and the pathways to aging and cancer
Derrick J. Rossi et al.
CELL (2008)
Lipid signalling in disease
Matthias P. Wymann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo
Chen Zhao et al.
CANCER CELL (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice
Yiguo Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Jiwang Zhang et al.
NATURE (2006)
Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners
P Várnai et al.
JOURNAL OF CELL SCIENCE (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation
A Catalano et al.
EMBO JOURNAL (2005)
Cancer stem cells: lessons from leukemia
JCY Wang et al.
TRENDS IN CELL BIOLOGY (2005)
The BCR-ABL story: Bench to bedside and back
S Wong et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
How do Abl family kinases regulate cell shape and movement?
SE Hernandez et al.
TRENDS IN CELL BIOLOGY (2004)
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development
JA Wertheim et al.
BLOOD (2003)
Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases
PJ Woodring et al.
JOURNAL OF CELL SCIENCE (2003)
Autoinhibition of Bcr-Abl through its SH3 domain
KM Smith et al.
MOLECULAR CELL (2003)
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
R Bhatia et al.
BLOOD (2003)
A role for Wnt signalling in self-renewal of haematopoietic stem cells
T Reya et al.
NATURE (2003)
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
J Lessard et al.
NATURE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Applying the principles of stem-cell biology to cancer
R Pardal et al.
NATURE REVIEWS CANCER (2003)
Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis
M Nieborowska-Skorska et al.
BLOOD (2002)
Critical role for Gab2 in transformation by BCR/ABL
M Sattler et al.
CANCER CELL (2002)
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
SM Graham et al.
BLOOD (2002)
Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling
SG Li et al.
EMBO JOURNAL (2001)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis
ZH Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Hedgehog and Wnt signaling pathways in cancer
J Taipale et al.
NATURE (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl
XW Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells
AW Gross et al.
ONCOGENE (2000)
Share Paper
